BXP, Inc. (BXP) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Loading...

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

|

|

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

Follow our journey and product updates

Product

Research a topic Stock screener Find companies Search for securities Load an existing portfolio Backtest

Learn

Thematic overview Develop asset-backed products Company evaluations Backtesting and benchmarking Thematic branded indices Build investment strategies with crypto

Company

How to use About us Blog

Team Research

There is currently no saved research for this page.

BXP, Inc. (BXP)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Company performance

Add to research

Current Price

as of Jul 15, 2025

$69.92

P/E Ratio

N/A

Market Cap

$12.16B

Description

Add to research

BXP, Inc. operates as a real estate investment trust. It develops, acquires, manages and owns a portfolio of Class A properties. The firm operates through the following geographical locations: Boston, New York, San Francisco and Washington. The company was founded by Mortimer Benjamin Zuckerman and Edward H. Linde in 1970 and is headquartered in Boston, MA.

Metrics

Add to research

Overview

HQBoston, MA
SectorFinance
IndustryReal Estate Investment Trusts
TickerBXP
Price$69.92-1.84%

Trading Information

Market cap$12.16B
Float99.76%
Average Daily Volume (1m)1,753,115
Average Daily Volume (3m)1,594,913
EPS-$0.03

Company

Revenue$3.43B
Rev growth (1yr)3.07%
Net income$61.18M
Gross margin34.84%
EBITDA margin54.09%
EBITDA$468.04M

EV$28.78B
EV/Revenue8.38
P/EN/A
P/S3.23
P/B2.08
Debt/Equity301.57

Documents

Add to research

SEC Filings

8-K (2025-05-20)

8-K (2025-04-29)

8-K (2025-04-23)

8-K (2025-03-31)

8-K (2025-01-28)

8-K (2024-10-29)

8-K (2024-08-26)

8-K (2024-07-30)

8-K (2024-07-25)

8-K (2024-06-20)

8-K (2024-05-24)

8-K (2024-04-30)

8-K (2024-01-30)

8-K (2023-11-01)

8-K (2023-10-02)

8-K (2023-08-01)

8-K (2023-06-06)

8-K (2023-05-23)

8-K (2023-05-18)

8-K (2023-05-15)

8-K (2023-04-25)

8-K (2023-03-02)

8-K (2023-02-01)

8-K (2023-01-09)

10-Q (2025-05-06)

10-Q (2024-11-05)

10-Q (2024-08-05)

10-Q (2024-05-10)

10-Q (2023-11-07)

10-Q (2023-08-07)

10-Q (2023-05-03)

10-K (2025-02-27)

10-K (2024-02-27)

10-K (2023-02-27)

Wikipedia

Boston_Properties,_Inc.

Factset Street Account

StreetAccount Earnings Call Q&A Summary: Boston Properties Q3 ($ 55.25, +1.75) (2023-11-02T15:42:37Z)

BXP exercises $315.0M accordion feature increasing its revolving credit facility capacity to more than $1.8B ($59.48, 0.00) (2023-10-02T11:17:36Z)

BXP agrees to sell a 45% interest in Kendall Square Life Sciences properties to Norges Bank Investment Management at a gross valuation of approximately $1.66B ($51.21, 0.00) (2023-11-14T11:04:12Z)

Boston Properties reports Q3 FFO $1.86 vs FactSet $1.84 ($53.50, 0.00) (2023-11-01T20:41:46Z)

Earnings Calls

Earnings Report 2025Q1

Earnings Report 2024Q4

Earnings Report 2024Q3

Earnings Report 2024Q2

Earnings Report 2024Q1

Earnings Report (2023-11-02)

Earnings Report (2023-08-02)

Factset

Factset Business Description

Ask a question

New feature

Thematic Research

View all of your research in one place. Toggle open the floating actions menu and click Open research sidebar to view your saved research for the current page.